These enhancements to our PrimaLOK™ SP Interspinous Fusion System strengthen our offering to spine surgeons seeking a low profile, minimally invasive approach.
Dallas, TX (PRWEB) October 23, 2012
OsteoMed Spine, a privately-held medical device company focused on developing next-generation, minimally disruptive devices for spinal surgery, announces several additions to its PrimaLOK™ SP Interspinous Fusion System. OsteoMed Spine will showcase its second generation instrumentation, smaller 4mm and 6mm implant sizes, and new sterile packaging, at the North American Spine Society (NASS) annual meeting, Oct. 23-27, 2012, in Dallas.
The PrimaLOK SP Interspinous Fusion System, commercially available in 2010, features next generation polyaxial technology for optimal placement and enhanced fixation to accommodate anatomic variations with minimal tissue disruption. The system provides posterior supplemental fixation for ALIF, TLIF, LLIF, PLIF, PLF and fusion revision procedures, often selected by surgeons as an alternative to pedicle screws without the potential complications. In addition to expanding from one to three instrument options to support various surgical techniques, OsteoMed Spine now offers the widest range of size options (4mm-18mm) of any interspinous fixation system.
David Muller, vice president of OsteoMed Spine, said, “These enhancements to our PrimaLOK SP Interspinous Fusion System strengthen our offering to spine surgeons seeking a low profile, minimally invasive approach. New instrument options help minimize operating room time and preserve patient anatomy, while the addition of 4mm and 6mm implant sizes accommodates the narrow spinous process opening at certain levels of the lumbar and thoracic spine.”
To learn more, visit OsteoMed Spine at NASS Booth #2709, or online at http://www.OsteoMed.com.
OsteoMed was founded in 1991 with the mission of improving patient outcomes through the development of advanced medical devices. Working in close collaboration with leading surgeons to create patient-focused solutions, OsteoMed develops innovative medical technologies for Spine, Small Bone Orthopedics, Craniomaxillofacial, and Neuro surgical specialties. As an emerging player in the spine industry since 2010, OsteoMed Spine’s specialty products include lumbar fixation devices PrimaLOKTM SP Interspinous Fusion System and PrimaLOKTM FF Facet Fixation System, along with biologics PrimaGRAFTTM ISS, an interspinous bio-implant, and PrimaGRAFTTM CS, a cancellous sponge. Dallas-based OsteoMed is a privately held company and a Colson Affiliate. More information can be found at http://www.OsteoMed.com.